Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Taouli, Bachir	Icahn School Of Medicine At Mount Sinai United States	Abbreviated MRI for HCC screening in cirrhotic patients	5R01CA249765-05	Guillermo Marquez, Ph.D.
Taratula, Oleh	Oregon State University United States	Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia	5R37CA234006-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah	Dana-Farber Cancer Inst United States	Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma	5R01CA230503-07	Nicholas Hodges, Ph.D.
Tearney, Guillermo J	Massachusetts General Hospital United States	Colorectal Cancer Screening with Optical Coherence Tomography	5R01CA280972-02	Matthew Young, Ph.D.
Temprosa, Marinella	George Washington University United States	22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center	2U01DK048489-28	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Temprosa, Marinella	George Washington University United States	22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center	2U01DK048489-28	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tennis, Meredith A	University Of Colorado Denver United States	Persistence and regression in lung premalignant lesions	1R01CA289576-01A1	Malgorzata Wojtowicz, M.D.
Tennis, Meredith A	University Of Colorado Denver United States	Modeling lung squamous cell carcinoma premalignancy and prevention	1R01CA298925-01
Terry, Kathryn L.	Brigham And Women'S Hospital United States	Changing Contraceptive Patterns and Ovarian Cancer Risk	5R01CA258679-05	Goli Samimi, Ph.D., M.P.H.
Tewari, Ashutosh K	Icahn School Of Medicine At Mount Sinai United States	Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men	1R01CA290438-01A1	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Thakur, Mathew Laxman	Thomas Jefferson University United States	Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer	5R01CA249921-05
Thangaraju, Muthusamy	Augusta University United States	Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis	5R01CA275840-03
Thompson, Patricia Ann	State University New York Stony Brook United States	Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk	5R01CA235720-05	Edward Sauter, M.D., Ph.D.
Thompson, Patricia Ann	University Of Arizona United States	University of Arizona Cancer Prevention Clinical Trials Network	2UG1CA242596-07	Donald Johnsey
Tollefsbol, Trygve O	University Of Alabama At Birmingham United States	Combinatorial epigenetic-based prevention of breast cancer	5R01CA178441-10	Gabriela Riscuta, M.D., CNS